These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 36974332)

  • 21. Efficacy of tapentadol ER for managing moderate to severe chronic pain.
    Afilalo M; Morlion B
    Pain Physician; 2013 Jan; 16(1):27-40. PubMed ID: 23340531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual μ-opioid receptor and norepinephrine reuptake mechanisms contribute to dezocine- and tapentadol-induced mechanical antiallodynia in cancer pain.
    Mao XF; Ahsan MZ; Apryani E; Tang XQ; Zhao MJ; Li XY; Wang YX
    Eur J Pharmacol; 2020 Jun; 876():173062. PubMed ID: 32173379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opioids for chronic non-cancer neuropathic pain. An updated systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration.
    Sommer C; Klose P; Welsch P; Petzke F; Häuser W
    Eur J Pain; 2020 Jan; 24(1):3-18. PubMed ID: 31705717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of pharmacotherapeutic analgesic response and safety profile of tapentadol with other opioids.
    Krtinic D; Rankovic GN; Cvetanovic A; Conic I; Mitic MT; Radic M; Prokin AL; Cevrljakovic M
    Pharmazie; 2024 Oct; 79(9):179-183. PubMed ID: 39407426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential contribution of opioid and noradrenergic mechanisms of tapentadol in rat models of nociceptive and neuropathic pain.
    Schröder W; Vry JD; Tzschentke TM; Jahnel U; Christoph T
    Eur J Pain; 2010 Sep; 14(8):814-21. PubMed ID: 20541444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tapentadol Prolonged Release for Chronic Pain: A Review of Clinical Trials and 5 Years of Routine Clinical Practice Data.
    Baron R; Eberhart L; Kern KU; Regner S; Rolke R; Simanski C; Tölle T
    Pain Pract; 2017 Jun; 17(5):678-700. PubMed ID: 27611642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tapentadol hydrochloride: a next-generation, centrally acting analgesic with two mechanisms of action in a single molecule.
    Tzschentke TM; Jahnel U; Kogel B; Christoph T; Englberger W; De Vry J; Schiene K; Okamoto A; Upmalis D; Weber H; Lange C; Stegmann JU; Kleinert R
    Drugs Today (Barc); 2009 Jul; 45(7):483-96. PubMed ID: 19834626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Conversion to tapentadol PR improves analgesia and quality of life in patients with severe and chronic pain despite using tramadol > 300 mg/d].
    Richter U; Waldmann-Rex S; Lehmann U
    Wien Klin Wochenschr; 2015 Jun; 127(11-12):477-87. PubMed ID: 25409951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tapentadol, but not morphine, selectively inhibits disease-related thermal hyperalgesia in a mouse model of diabetic neuropathic pain.
    Christoph T; De Vry J; Tzschentke TM
    Neurosci Lett; 2010 Feb; 470(2):91-4. PubMed ID: 20026182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the norepinephrine transporter (NET) inhibition on μ-opioid receptor (MOR)-induced anti-nociception in a bone cancer pain model.
    Ono H; Nakamura A; Kanbara T; Minami K; Shinohara S; Sakaguchi G; Kanemasa T
    J Pharmacol Sci; 2014; 125(3):264-73. PubMed ID: 24965165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of post-herpes zoster pain with tramadol. Results of an open pilot study versus clomipramine with or without levomepromazine].
    Göbel H; Stadler T
    Drugs; 1997; 53 Suppl 2():34-9. PubMed ID: 9190323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Undesired side effects of tapentadol in comparison to oxycodone. A meta-analysis of randomized controlled comparative studies].
    Merker M; Dinges G; Koch T; Kranke P; Morin AM
    Schmerz; 2012 Feb; 26(1):16-26. PubMed ID: 22366930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The antinociceptive and antihyperalgesic effect of tapentadol is partially retained in OPRM1 (μ-opioid receptor) knockout mice.
    Kögel B; De Vry J; Tzschentke TM; Christoph T
    Neurosci Lett; 2011 Mar; 491(2):104-7. PubMed ID: 21232580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Efficacy of Tapentadol for Neuropathic Pain in Cancer].
    Takahara Y; Tanahashi J; Murota K; Imai M; Takagi Y; Kimata T
    Gan To Kagaku Ryoho; 2021 Jun; 48(6):811-814. PubMed ID: 34139729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective, multicenter, open-label study of the clinical efficacy of tapentadol extended-release in the treatment of cancer-related pain and improvement in the quality of life of opioid-naïve or opioid-resistant patients.
    Jung JY; Chon HJ; Choi YJ; Yeon SE; Choi SY; Lee KH
    Support Care Cancer; 2022 Jul; 30(7):6103-6112. PubMed ID: 35420330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac Arrest Following Drug Abuse with Intravenous Tapentadol: Case Report and Literature Review.
    Khaja M; Lominadze G; Millerman K
    Am J Case Rep; 2017 Jul; 18():817-821. PubMed ID: 28729524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prescribing trend of tapentadol in a Sydney local health district.
    Mirabella J; Ravi D; Chiew AL; Buckley NA; Chan BS
    Br J Clin Pharmacol; 2022 Sep; 88(9):3929-3935. PubMed ID: 35763675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical pharmacology of tramadol and tapentadol, and their therapeutic efficacy in different models of acute and chronic pain in dogs and cats.
    Domínguez-Oliva A; Casas-Alvarado A; Miranda-Cortés AE; Hernández-Avalos I
    J Adv Vet Anim Res; 2021 Sep; 8(3):404-422. PubMed ID: 34722739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterisation of tramadol, morphine and tapentadol in an acute pain model in Beagle dogs.
    Kögel B; Terlinden R; Schneider J
    Vet Anaesth Analg; 2014 May; 41(3):297-304. PubMed ID: 24576316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Appropriate use of tapentadol: focus on the optimal tapering strategy.
    Vellucci R; Fornasari D
    Curr Med Res Opin; 2023 Jan; 39(1):123-129. PubMed ID: 36427080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.